Allurion Technologies (ALURD) Share-based Compensation (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Share-based Compensation came in at $1.0 million in Q1 2026, up 11.48% YoY from $897000.0 in Q1 2025, and up 42.45% on a QoQ basis from $702000.0 in Q4 2025.
Allurion Technologies (ALURD) Share-based Compensation (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Share-based Compensation data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Share-based Compensation rose 11.48% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 70.6% YoY) and the FY2025 annual result came in at $3.1 million, up 2.95% from the prior year.
- Share-based Compensation improved to $1.0 million in Q1 2026, from $702000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $5.5 million in Q3 2023 to a low of $89000.0 in Q2 2022.
- A 5-year average of $995187.5 and a median of $753500.0 in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation jumped 5855.91% — and 2024, when it plunged 84.47%.
- Tracing ALURD's Share-based Compensation over 5 years: stood at $182000.0 in 2022, then surged by 1003.3% to $2.0 million in 2023, then sank by 58.22% to $839000.0 in 2024, then declined by 16.33% to $702000.0 in 2025, then jumped by 42.45% to $1.0 million in 2026.
- The last three Share-based Compensation figures came in at $1.0 million (Q1 2026), $702000.0 (Q4 2025), and $531000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 702,000.00 |
| Dec 31, 2025 | 702,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 897,000.00 |
| Mar 31, 2025 | 897,000.00 |
| Dec 31, 2024 | 839,000.00 |
| Dec 31, 2024 | 839,000.00 |
| Sep 30, 2024 | 860,000.00 |
| Sep 30, 2024 | 860,000.00 |
| Jun 30, 2024 | 805,000.00 |
| Jun 30, 2024 | 805,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Dec 31, 2023 | 2.01 Mn |
| Dec 31, 2023 | 2.01 Mn |